Data Composite

Drug Recalls

Recent drug recall reports from the FDA (US) and Health Canada, newest first. Each entry links to the full record -- product description, reason for recall, and severity classification -- refreshed daily.

Apo-Fluoxetine

Canada Type III Ongoing · initiated 2026-04-10

Product safety. Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health con…

The Harvard Drug Group LLC

US Class II Ongoing · initiated 2026-04-09

Failed Capsule Specifications: Out of specification results obtained during routine stability testing for Loss on Drying of Capsule Shells.

Apotex Corp.

US Class II Ongoing · initiated 2026-04-08

Defective container: defect in a batch of bottle caps, specifically involving dislodged or missing cap liners.

Blaine Labs Inc

US Class II Ongoing · initiated 2026-04-08

CGMP Deviations; the firm discontinued required stability testing for products on the market still within expiry

Blaine Labs Inc

US Class II Ongoing · initiated 2026-04-08

CGMP Deviations; the firm discontinued required stability testing for products on the market still within expiry

Blaine Labs Inc

US Class I Ongoing · initiated 2026-04-08

Microbial contamination of Non-Sterile Product: samples identified the presence of Lysinibacillus fusiformis and other Bacillus spp

Blaine Labs Inc

US Class II Ongoing · initiated 2026-04-08

CGMP Deviations; the firm discontinued required stability testing for products on the market still within expiry

Blaine Labs Inc

US Class II Ongoing · initiated 2026-04-08

CGMP Deviations; product manufactured in the same facility under the same conditions as the product found to be contaminated

Blaine Labs Inc

US Class II Ongoing · initiated 2026-04-08

CGMP Deviations; the firm discontinued required stability testing for products on the market still within expiry

Blaine Labs Inc

US Class II Ongoing · initiated 2026-04-08

CGMP Deviations: product manufactured in the same facility under the same conditions as the product found to be contaminated

Blaine Labs Inc

US Class II Ongoing · initiated 2026-04-08

CGMP Deviations; the firm discontinued required stability testing for products on the market still within expiry

Hikma Pharmaceuticals USA INC

US Class II Ongoing · initiated 2026-04-07

This recall is being conducted due to out of specification assay results in a limited number of bottles that were stored on side.

Water-Jel Technologies, LLC

US Class III Ongoing · initiated 2026-04-07

Failed PH Specifications

Teva Pharmaceuticals USA, Inc

US Class II Ongoing · initiated 2026-04-06

Failed Impurities/Degradation Specifications: Out of specification for specific impurity Tretinoin

Fresenius Medical Care Holdings, Inc.

US Class II Ongoing · initiated 2026-04-06

Lack of Assurance of Sterility: Potential leaks from perforations in bags.

Fresenius Medical Care Holdings, Inc.

US Class II Ongoing · initiated 2026-04-06

Lack of Assurance of Sterility: Potential leaks from perforations in bags.

Huons Co., Ltd.

US Class II Ongoing · initiated 2026-04-02

Lack of Assurance of Sterility

Huons Co., Ltd.

US Class II Ongoing · initiated 2026-04-02

Lack of Assurance of Sterility

Huons Co., Ltd.

US Class II Ongoing · initiated 2026-04-02

Lack of Assurance of Sterility

Huons Co., Ltd.

US Class II Ongoing · initiated 2026-04-02

Lack of Assurance of Sterility

B BRAUN MEDICAL INC

US Class II Ongoing · initiated 2026-04-02

Lack of Assurance of Sterility; potential for leakage from the diaphragm port once the foil is removed.

B BRAUN MEDICAL INC

US Class II Ongoing · initiated 2026-04-02

Lack of Assurance of Sterility; potential for leakage from the diaphragm port once the foil is removed.

B BRAUN MEDICAL INC

US Class II Ongoing · initiated 2026-04-02

Lack of Assurance of Sterility; potential for leakage from the diaphragm port once the foil is removed.

B BRAUN MEDICAL INC

US Class II Ongoing · initiated 2026-04-02

Lack of Assurance of Sterility; potential for leakage from the diaphragm port once the foil is removed.

Various Ophthalmic Solutions from Aved

Canada Type III Ongoing · initiated 2026-04-02

Unauthorized product. Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any heal…